• Author Q&A Series: H pylori-associated Gastric Cancer

Author Q&A Series: H pylori-associated Gastric Cancer

Gastric tumors and tissues from humans and mice accumulate somatic mutations in various genes in the gastric mucosa upon Helicobacter pylori infection, researchers report in the August issue of Gastroenterology. In the study, Takahiro Shimizu et al. show that increased cytidine deaminase activity in these tissues promotes the accumulation of these mutations and might

Read more
  • Review: LGR5 and Intestinal Stem Cells

Review: LGR5 and Intestinal Stem Cells

Since the discovery of LGR5 as a marker of intestinal stem cells, we have learned a great deal about the intestinal crypt stem cell niche. In the August issue of Gastroenterology Bon-Kyoung Koo and Hans Clevers review the discovery of crypt base columnar cells as LGR5+ adult stem cells and

Read more

How Can We Tell if Patients are Still at Risk for HCC after HCV Therapy?

For patients with chronic Hepatitis C virus infection, high levels of α-fetoprotein after therapy can identify those at risk for hepatocellular carcinoma (HCC), researchers report in the July issue of Clinical Gastroenterology and Hepatology. In persons with chronic HCV infection, lack of sustained virologic response (SVR) 24 weeks after the end

Read more